New Medicine by Design-funded research advances an under-skin cell therapy for type 1 diabetes
Research shows that transplanted pancreatic cells were able to survive in animal hosts.
Medicine by Design symposium panel explores strategies for strengthening Canada’s bioinnovation ecosystem
Themes like lessons learned from COVID-19, symbiotic partnerships and access to risk capital emerge in wide-ranging discussion.
Enabling long-lasting cell therapy for diabetes without injection
Is immunoengineering the key to ensuring that cell therapies can treat disease?
Medicine by Design symposium to celebrate systems approaches in advancing regenerative medicine and health innovation
The 6th Annual Symposium on Dec. 9 and 10 will feature renowned experts to explore cutting-edge concepts in health research and innovation.
Medicine by Design-funded researchers generate cells that will impact treatments for bile duct disorders as a result of cystic fibrosis
Newly-generated cells may lead to a deeper understanding of bile duct disease and be a powerful tool for finding new treatments.
First Medicine by Design entrepreneur-in-residence to help accelerate research discoveries into therapies for patients
Entrepreneur-in-residence to work on bridging the gap between foundational research funded by Medicine by Design and the creation of products or ventures that will impact human health.
Medicine by Design and partners invite trainees to explore entrepreneurship through enhanced Building a Biotech Venture program
The program’s second year includes new partnerships, enhanced educational opportunities and more research funding.
New Medicine by Design-funded method for testing muscle repair in a dish to impact development of stem cell-based therapies
Scientists at the University of Toronto have discovered a novel way to test self-repair of skeletal muscle, a method with the potential to accelerate treatments for diseases like muscular dystrophy.
Medicine by Design partners with the Ajmera Transplant Centre to translate the next generation of regenerative medicine therapies to the clinic
Regen Med in the Clinic, a new partnership between the Ajmera Transplant Centre and Medicine by Design, aims to create linkages between clinicians and scientists & engineers.
Healthier aging: Ending chronic disease through regeneration
Convergence is the key to advancing regenerative medicine and paving the way for novel approaches to treating disease and even preventing it before it starts. This post is just one of many covering the topic of aging as part of Signal’s sixth annual blog carnival.
Medicine by Design’s Pivotal Experiment Fund invests $1 million in four research teams to bridge the “valley of death” funding gap
Funding gives cutting-edge regenerative medicine concepts impacting heart disease, lung transplantation, degenerative brain disease and end-stage liver disease a pathway to clinical translation.
Medicine by Design-sponsored Human Cell Atlas meeting to unite researchers on international effort to map every human cell
Meeting from August 25 to 27 will focus on development and pediatric communities
Medicine by Design-funded research uncovers important gap in knowledge of tissue development
Computational biology study found two fundamental mechanisms involved in the cell play important roles and may help better control cells used in regenerative medicine applications
Three regenerative medicine experts join the Medicine by Design community through the New Investigators program
Three investigators join a cohort of 15 faculty members who have been supported by Medicine by Design’s New Investigators program.
Venture formed in the Medicine by Design community, Liberum, aims to make desktop protein manufacturing a reality
What if manufacturing proteins was a simple as brewing a cup of coffee?